Jilin Province Huinan Changlong Bio-pharmacy Company Limited Stock
Equities
8049
CNE100000130
Pharmaceuticals
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.64 HKD | 0.00% | -10.87% | 0.00% |
Sales 2022 | 842M 116M 909M | Sales 2023 | 842M 116M 909M | Capitalization | 835M 115M 902M |
---|---|---|---|---|---|
Net income 2022 | 194M 26.8M 210M | Net income 2023 | 148M 20.44M 160M | EV / Sales 2022 | -0.74 x |
Net cash position 2022 | 1.05B 145M 1.13B | Net cash position 2023 | 578M 79.79M 624M | EV / Sales 2023 | 0.31 x |
P/E ratio 2022 |
2.22
x | P/E ratio 2023 |
5.63
x | Employees | 848 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 23.02% |
1 week | -10.87% | ||
Current month | -5.75% | ||
1 month | +7.89% | ||
3 months | -3.53% | ||
6 months | +27.13% |
Managers | Title | Age | Since |
---|---|---|---|
Bao Gang Zhao
DFI | Director of Finance/CFO | 57 | 96-07-31 |
Hong Zhang
CHM | Chairman | 69 | 89-09-30 |
Xiang Fu Xu
CTO | Chief Tech/Sci/R&D Officer | 55 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Hong Zhang
CHM | Chairman | 69 | 89-09-30 |
Xiao Guang Zhang
BRD | Director/Board Member | 60 | 90-11-30 |
Bao Gang Zhao
DFI | Director of Finance/CFO | 57 | 96-07-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-01 | 1.64 | 0.00% | 36 000 |
24-04-30 | 1.64 | +5.81% | 215,800 |
24-04-29 | 1.55 | -1.27% | 404,000 |
24-04-26 | 1.57 | -15.14% | 1,452,000 |
24-04-25 | 1.85 | +1.65% | 332,000 |
Delayed Quote Hong Kong S.E., May 01, 2024 at 09:57 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
0.00% | 117M | |
-3.81% | 86.85B | |
+2.76% | 40.16B | |
-16.48% | 31.28B | |
+57.86% | 25.27B | |
-13.58% | 15.33B | |
-9.12% | 11.96B | |
-42.56% | 11.61B | |
+6.89% | 8.83B | |
-6.43% | 7.94B |
- Stock Market
- Equities
- 8049 Stock